Prenetics Announces Second Quarter 2022 Financial Results and Raises Full Year Adjusted EBITDA Outlook
September 09, 2022 09:02 ET
|
Prenetics Limited
Revenue of US$51.7 million in the second quarter of 2022Loss from operations of US$(17.9) million and adjusted EBITDA1 of US$6.5 million in the same periodRaises full year adjusted EBITDA guidance to...
Prenetics Announces First Quarter 2022 Financial Results After a Successful Listing on the Nasdaq under the Ticker “PRE”
June 06, 2022 06:45 ET
|
Prenetics Limited
LONDON and HONG KONG, June 06, 2022 (GLOBE NEWSWIRE) -- Prenetics Global Limited (NASDAQ: PRE) (“Prenetics” or the “Company”), a global leader in genomic and diagnostic testing, today announced its...
Prenetics Rings the Opening Bell and Debuts on Nasdaq
May 18, 2022 18:30 ET
|
Prenetics Limited
Prenetics becomes the first Hong Kong unicorn to list on Nasdaq and its shares began trading on May 18 under ticker “PRE”At Least US$260M of Proceeds from the Business Combination, Cash and Trade...